Among them, TRPV6 is overexpressed in a number of cancer cell types and participates in the progression of prostate cancer [19], acquiring its oncogenic potential via Orai1/TRPC1-dependent translocation to the plasma membrane [20]. This evidence concerns the gene TRPC1 and cancer.